| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
3.525 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
3.525 |
Evidence |
|
| SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
JAK1 |
|
3.525 |
Evidence |
|
| TNFSF12 |
TNFSF12, APO3L, UNQ181/PRO207, DR3LG: Tumor necrosis factor ligand superfamily m |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
3.525 |
Evidence |
|
| CIITA |
CIITA, MHC2TA: MHC class II transactivator |
RPS10 |
RPS10: 40S ribosomal protein S10 |
3.525 |
Evidence |
|
| LPA |
LPA: Apolipoprotein(a) precursor |
SERPINA4 |
SERPINA4, KST, PI4: Kallistatin precursor |
3.525 |
Evidence |
|
| F12 |
F12: Coagulation factor XII precursor |
SERPINA10 |
SERPINA10, ZPI, UNQ707/PRO1358: Protein Z-dependent protease inhibitor precursor |
3.525 |
Evidence |
|
| B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
3.525 |
Evidence |
|
| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
3.525 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
3.525 |
Evidence |
|
| SERPINA10 |
SERPINA10, ZPI, UNQ707/PRO1358: Protein Z-dependent protease inhibitor precursor |
HP |
HP: Haptoglobin precursor [Contains: Haptoglobin alpha chain; Haptoglobin beta c |
3.525 |
Evidence |
|
| C1R |
C1R: Complement C1r subcomponent precursor |
SERPINA4 |
SERPINA4, KST, PI4: Kallistatin precursor |
3.525 |
Evidence |
|
| CIITA |
CIITA, MHC2TA: MHC class II transactivator |
IRAK1 |
IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 |
3.525 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
3.512 |
Evidence |
|
| MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
GRIK2 |
GRIK2, GLUR6: Glutamate receptor, ionotropic kainate 2 precursor |
3.512 |
Evidence |
|
| CTLA4 |
CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
3.51 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
BAD |
BAD, BBC6, BCL2L8: Bcl2 antagonist of cell death |
3.51 |
Evidence |
|
| SLC2A1 |
SLC2A1, GLUT1: Solute carrier family 2, facilitated glucose transporter member 1 |
DSTN |
DSTN, ACTDP, DSN: Destrin |
3.51 |
Evidence |
|
| JUP |
JUP, CTNNG, DP3: Junction plakoglobin |
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
3.51 |
Evidence |
|
| JUP |
JUP, CTNNG, DP3: Junction plakoglobin |
CREBBP |
CREBBP, CBP: CREB-binding protein |
3.51 |
Evidence |
|
| RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
MAP3K10 |
MAP3K10, MLK2, MST: Mitogen-activated protein kinase kinase kinase 10 |
3.502 |
Evidence |
|
| RGL2 |
RGL2, RAB2L: Ral guanine nucleotide dissociation stimulator-like 2 |
RAP1B |
RAP1B, OK/SW-cl.11: Ras-related protein Rap-1b precursor |
3.497 |
Evidence |
|
| APS |
SH2B2, APS: SH2B adapter protein 2 |
PECAM1 |
PECAM1: Platelet endothelial cell adhesion molecule precursor |
3.495 |
Evidence |
|
| RGS7 |
RGS7: Regulator of G-protein signaling 7 |
HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
3.495 |
Evidence |
|
| PECAM1 |
PECAM1: Platelet endothelial cell adhesion molecule precursor |
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
3.495 |
Evidence |
|
- 
-